Talis Biomedical Corp Price on June 27, 2024
If you're considering investing in Talis Pink Sheet, it is important to understand the factors that can impact its price. Talis Biomedical Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.76, which indicates the firm had a -0.76% return per unit of risk over the last 3 months. Talis Biomedical Corp exposes fifteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Talis Biomedical's Risk Adjusted Performance of (0.13), variance of 110.16, and Coefficient Of Variation of (556.77) to confirm the risk estimate we provide.
Talis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Talis |
Sharpe Ratio = -0.7633
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TLIS |
Estimated Market Risk
51.36 actual daily | 96 96% of assets are less volatile |
Expected Return
-39.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.76 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Talis Biomedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Talis Biomedical by adding Talis Biomedical to a well-diversified portfolio.
Related Headline
Bluejay Diagnostics Headline on 27th of June 2024
Bluejay Diagnostics Announces Pricing of 8.75 Million Underw... by finance.yahoo.com
ACTON, Mass., June 27, 2024 -- Bluejay Diagnostics, Inc. , a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately 8.75 million, before deducting underwriting discounts and other estimated expenses payable by the Co
Talis Biomedical Valuation on June 27, 2024
It is possible to determine the worth of Talis Biomedical on a given historical date. On June 27, 2024 Talis was worth 8.25 at the beginning of the trading date compared to the closed value of 8.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Talis Biomedical pink sheet. Still, in general, we apply an absolute valuation method to find Talis Biomedical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Talis Biomedical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Talis Biomedical's related companies.
Open | High | Low | Close | Volume | |
8.51 | 8.51 | 8.26 | 8.50 | 7,285 | |
06/27/2024 | 8.25 | 8.89 | 8.25 | 8.62 | 7,447 |
8.40 | 8.90 | 8.31 | 8.66 | 9,272 |
Backtest Talis Biomedical | | | Talis Biomedical History | | | Talis Biomedical Valuation | Previous | Next |
Talis Biomedical Trading Date Momentum on June 27, 2024
On June 28 2024 Talis Biomedical Corp was traded for 8.66 at the closing time. The top price for the day was 8.90 and the lowest listed price was 8.31 . The trading volume for the day was 9.3 K. The trading history from June 28, 2024 was a factor to the next trading day price appreciation. The trading price change against the next closing price was 0.46% . The trading price change against the current closing price is 0.81% . |
Talis Biomedical Corp Fundamentals Correlations and Trends
By evaluating Talis Biomedical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Talis Biomedical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Talis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Talis Biomedical Pink Sheet history
Talis Biomedical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Talis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Talis Biomedical Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Talis Biomedical stock prices may prove useful in developing a viable investing in Talis Biomedical
Talis Biomedical Corporation operates as a molecular diagnostic company. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California. Talis Biomedical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.
Talis Biomedical Pink Sheet Technical Analysis
Talis Biomedical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Talis Biomedical Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Talis Biomedical Corp cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Talis Biomedical December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Talis Biomedical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Talis Biomedical shares will generate the highest return on investment. By undertsting and applying Talis Biomedical pink sheet market strength indicators, traders can identify Talis Biomedical Corp entry and exit signals to maximize returns
Talis Biomedical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Talis Biomedical's price direction in advance. Along with the technical and fundamental analysis of Talis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Talis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.13) | |||
Jensen Alpha | (1.85) | |||
Total Risk Alpha | (3.65) | |||
Treynor Ratio | 5.84 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Talis Pink Sheet
If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stocks Directory Find actively traded stocks across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |